1-11 of 11
Michelle Byrtek, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dynamics of Activated CD8+ T-cells and Decreased Osteoclasts in the Tumor Microenvironment are Associated with Clinical Efficacy of Anti-PD-L1 and Anti-CD38 Combination Treatment in Relapsed or Refractory Multiple Myeloma

Aparna Raval, PhD, Hearn Jay Cho, MD PhD, Cherie Green, BS, Elisabeth Wassner Fritsch, PharmD, Connie Ma, MS, Naomi Chang, MSc, Mark Yan, PhD, Mark Kockx, MD PhD, Shine Shen, MS, Ling-Yuh Huw, PhD, Emily Balestiere, BA, Marina Lipkind, BS, Huang Huang, MSc, Michelle Byrtek, PhD, Dawn Colburn, PharmD, BCOP, Sandy W. Wong, Jeffrey M. Venstrom, MD PhD, Joanne I Adamkewicz, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1907.
https://doi.org/10.1182/blood-2019-123652
Published: 2019
Journal Articles

Disease Characteristics, Treatment Patterns, and Outcomes of Follicular Lymphoma in Patients 40 Years of Age and Younger: An Analysis from the National LymphoCare Study

Carla Casulo, MD, Michelle Byrtek, PhD, Keith L Dawson, DNP, MS, Xiaolei Zhou, MS, Christopher R. Flowers, MD, Charles M. Farber, MD PhD, John D Hainsworth, MD, James R Cerhan, MD PhD, Brian K Link, MD, Jonathan W Friedberg, MD
Journal: Blood
Blood (2014) 124 (21): 3044.
https://doi.org/10.1182/blood.V124.21.3044.3044
Published: 2014
Journal Articles

A Proposed Prognostic Model For Overall Survival In The Oldest Old (>80 Years Old) Follicular Lymphoma Patients

Chadi Nabhan, MD, FACP, Michelle Byrtek, PhD, Keith L Dawson, DNP, RN, Xiaolei Zhou, MS, Brian K Link, MD, Jonathan W. Friedberg, MD, Andrew D. Zelenetz, MD, PhD, James R Cerhan, MD, PhD, Christopher R. Flowers, MD, MS
Journal: Blood
Blood (2013) 122 (21): 3058.
https://doi.org/10.1182/blood.V122.21.3058.3058
Published: 2013
Journal Articles

PET Compared With CT As a Prognosticator After Rituximab Induction Therapy In Follicular Lymphoma: Report From The National Lymphocare Study

Ida Wong-Sefidan, MD, Michelle Byrtek, PhD, Xiaolei Zhou, MS, Jonathan W. Friedberg, MD, Christopher Flowers, MD, Brian K Link, MD, Andrew D. Zelenetz, MD, PhD, Keith L Dawson, DNP, RN, Erin G. Reid, MD, MS
Journal: Blood
Blood (2013) 122 (21): 4245.
https://doi.org/10.1182/blood.V122.21.4245.4245
Published: 2013
Journal Articles

Early Relapse Of Follicular Lymphoma After R-CHOP Uniquely Defines Patients At High Risk For Death: An Analysis From The National Lymphocare Study

Carla Casulo, MD, Michelle Byrtek, PhD, Keith L. Dawson, DNP, RN, Xiaolei Zhou, MS, Charles Farber, MD, Christopher R. Flowers, MD, MS, John D. Hainsworth, MD, Brian K Link, MD, Andrew D. Zelenetz, MD, PhD, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2013) 122 (21): 510.
https://doi.org/10.1182/blood.V122.21.510.510
Published: 2013
Journal Articles

Age Differences in Disease Characteristics, Patterns of Care, and Outcomes of Follicular Lymphoma (FL) in the United States (US): Report From the National Lymphocare Study (NLCS)

Chadi Nabhan, MD, FACP, Michelle Byrtek, PhD, Shadi Latta, MD, Keith L Dawson, MS, RN, Xiaolei Zhou, MS, Brian K Link, MD, Jonathan W. Friedberg, MD, James R Cerhan, MD, PhD, Christopher R. Flowers, MD
Journal: Blood
Blood (2012) 120 (21): 3708.
https://doi.org/10.1182/blood.V120.21.3708.3708
Published: 2012
Journal Articles

Patterns of Delivery of Chemoimmunotherapy to Patients with Follicular Lymphoma in the United States: Results of the National Lymphocare Study

Peter Martin, MD, Brian K Link, MD, Michelle Byrtek, PhD, Keith L Dawson, MS, RN, Ryan M Ziemiecki, MS, Jonathan W. Friedberg, MD, James R Cerhan, MD, PhD, Christopher R. Flowers, MD
Journal: Blood
Blood (2012) 120 (21): 3702.
https://doi.org/10.1182/blood.V120.21.3702.3702
Published: 2012
Journal Articles

A Comparison of the Effectiveness of First-Line Chemoimmunotherapy Regimens for Follicular Lymphoma (FL) Used in the United States

Loretta Nastoupil, MD, Rajni Sinha, MD, MRCP, Michelle Byrtek, PhD, Michael Taylor, PharmD, PhD, James R Cerhan, MD, PhD, Jonathan Friedberg, MD, Brian K Link, MD, Ryan M Ziemiecki, MS, Jamie H. Hirata, PharmD, Christopher R Flowers, MD
Journal: Blood
Blood (2011) 118 (21): 97.
https://doi.org/10.1182/blood.V118.21.97.97
Published: 2011
Journal Articles

Examining the Outcomes of Watchful Waiting (WW) Among US Patients with Advanced Stage Follicular Lymphoma (FL)

Rajni Sinha, MD, MRCP, Michelle Byrtek, PhD, Nutan J. DeJoubner, MD, Ajay K. Nooka, MD, MPH, FACP, Michael Taylor, PharmD, PhD, James R Cerhan, MD, PhD, Jonathan Friedberg, MD, Ryan M Ziemiecki, MS, Jamie H. Hirata, PharmD, Brian K Link, MD, Christopher R Flowers, MD
Journal: Blood
Blood (2011) 118 (21): 775.
https://doi.org/10.1182/blood.V118.21.775.775
Published: 2011
Journal Articles

Characteristics and Effectiveness of Rituximab (R) Maintenance Regimens Among US Patients Diagnosed with Follicular Lymphoma (FL) 2004–2007,

Loretta Nastoupil, MD, Rajni Sinha, MD, MRCP, Michelle Byrtek, PhD, Xiaolei Zhou, Michael Taylor, PharmD, PhD, James R Cerhan, MD, PhD, Jonathan Friedberg, MD, Brian K Link, MD, Jamie H. Hirata, PharmD, Christopher R Flowers, MD
Journal: Blood
Blood (2011) 118 (21): 3708.
https://doi.org/10.1182/blood.V118.21.3708.3708
Published: 2011
Journal Articles

Does An Anthracycline Make a Difference for Follicular Lymphoma (FL) Grade 3? Patterns of Care and Treatment Outcomes of Grade 3 FL From the National LymphoCare Study (NLCS)

Christopher R Flowers, MD, MS, Michael Taylor, PharmD, PhD, Michelle Byrtek, PhD, Jamie H. Hirata, PharmD, James Cerhan, MD, PhD, John Hainsworth, MD, Brian Link, Thomas P. Miller, MD, Hildy Dillon, MPH, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2010) 116 (21): 1768.
https://doi.org/10.1182/blood.V116.21.1768.1768
Published: 2010